Improving Executive Control in Cognitively Healthy Older Adults: the MUltitasking STrategy (MUST) Study
Rutgers, The State University of New Jersey · with National Institute on Aging (NIA) · NCT06995638
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 60–75 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 130
- US sites recruiting
- 1
- Study start
- December 10, 2025
- Record last updated
- December 15, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Developing efficient cognitive intervention for cognitively health older adults is a major public health goal, due to its potential for reducing age-related cognitive decline and Alzheimer's disease/dementia risk. Executive Control is a relevant cognitive target since it declines with aging and is critical for multi-tasking in daily life. The proposed research investigates whether playing a web-based cognitive complex game (the Breakfast Game) impacts cognitive performance in cognitively healthy older adults. To be enrolled in the study, participants will be asked to undergo a cognitive sassessment, health questionnires, and a blood exam. The intervention consist in one educational session on healthy aging, and 10 one-hour cognitive training sessions 2-3 times a week over one month. Participants will be asked to repeat the cognitive assessment within 1-2 weeks after the intervention, and after three months.
Being studied: Web-based Cognitive Training (with strategy); Web-based Cognitive Training (without strategy)
Conditions: Healthy Aging; Alzheimer's Disease (AD)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 60-75
- Adequate English proficiency
- Willingness to adhere to training protocol:
- Attend 2 in-person assessments
- Attend a blood test
- Attend online intervention sessions and online follow-up assessment
Exclusion Criteria
- Low test scores (below 26 on the Montreal Cognitive Assessment)
- Known history of cognitive impairment, dementia, stroke, seizure disorder, or other neuropsychiatric condition judged to impact cognitive performance.
- Taking medications known to influence cognitive performance.
- Sensory (e.g. visual, auditory) or physical (e.g. severe arthritic, orthopedic, neurologic) impairment incompatible with use of a standard computer workstation.
- Enrolled in a concurrent study that could affect the outcome of this study.
Recruiting US locations
Rutgers New Jersey Medical School, Behavior Health Sciences Building, F-Level
Newark, NJ 07103
Site contact: Thamiris Gonçalves Clinical Research Coordinator, MS · 973-972-2977 · engaging.lab@rutgers.edu
Study contacts (from the official record)
- Thamiris Golçalves Clinical Research Coordinator, MS · 973-972-2977 · engaging.lab@rutgers.edu
- Ana Staniscia Associate Research, MS · ana.staniscia@rutgers.edu
Similar studies in New Jersey
All neurology studies in New Jersey →- RecruitingHealthy volunteersPhase 1
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
Eli Lilly and Company
- Location
- Marlton, NJ + 5 other US sites
- Eligibility basics
- Ages 45–85
- RecruitingPhase 2
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
Sanofi
- Location
- Springfield, NJ + 9 other US sites
- Eligibility basics
- Ages 55–85
- RecruitingPhase 3
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Rapport Therapeutics Inc.
- Location
- Hackensack, NJ + 13 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Merck Sharp & Dohme LLC
- Location
- Marlton, NJ + 34 other US sites
- Eligibility basics
- Ages 50–85